Literature DB >> 25149064

Mycoplasma hyorhinis induces epithelial-mesenchymal transition in gastric cancer cell MGC803 via TLR4-NF-κB signaling.

Hongying Duan1, Like Qu1, Chengchao Shou2.   

Abstract

Our previous works showed chronic infection of Mycoplasma hyorhinis (M. hyorhinis) was associated with gastric cancer metastasis, but the mechanisms were unknown. Herein, we found M. hyorhinis induced epithelial-mesenchymal transition (EMT) in gastric cancer cell MGC803, which was counteracted by inhibitor of NF-κB signaling or p65 knockdown. Furthermore, we found that TLR4 associated with p37, a membrane protein of M. hyorhinis. Knock-down or inhibition of TLR4 antagonized M. hyorhinis-induced NF-κB signaling, EMT, and cell migration. Thus, M. hyorhinis induces EMT and promotes cell migration via TLR4-NF-κB signaling, which provides a clue to the pathogenesis of M. hyorhinis in gastric cancer.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  EMT; Gastric cancer; Mycoplasma hyorhinis; NF-κB; TLR4

Mesh:

Substances:

Year:  2014        PMID: 25149064     DOI: 10.1016/j.canlet.2014.08.018

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  Mycoplasma hyorhinis infection promotes tyrosine kinase inhibitor (TKI) resistance in lung adenocarcinoma patients.

Authors:  Yueyu Dai; Fangyuan Zhong; Wenbin Liu; Qibin Song; Weiguo Hu
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-06       Impact factor: 4.553

2.  Identification of tissue-specific microbial profile of esophageal squamous cell carcinoma by full-length 16S rDNA sequencing.

Authors:  Weitao Shen; Derong Tang; Ping Wan; Zhenyan Peng; Mingjun Sun; Xinxin Guo; Ran Liu
Journal:  Appl Microbiol Biotechnol       Date:  2022-04-18       Impact factor: 4.813

3.  Nucleic acid aptamer controls mycoplasma infection for inhibiting the malignancy of esophageal squamous cell carcinoma.

Authors:  Yibin Zhang; Hui Zhang; Xing Sun; Tianhuan Peng; Tiantian Xie; Yijun Yuan; Junxiao Guo; Yinglei Chen; Lingli Zhou; Neng Ling; Hui Li; Ling Li; Lin Zhang; Xiaodong Li; Long Liang; Jing Liu; Mao Ye; Weihong Tan
Journal:  Mol Ther       Date:  2022-02-18       Impact factor: 12.910

Review 4.  Epithelial-mesenchymal transition in gastric cancer.

Authors:  Lei Huang; Ruo-Lin Wu; A-Man Xu
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

Review 5.  Toll-like receptors: exploring their potential connection with post-operative infectious complications and cancer recurrence.

Authors:  S D Gowing; J J Cool-Lartigue; J D Spicer; A J E Seely; L E Ferri
Journal:  Clin Exp Metastasis       Date:  2020-01-23       Impact factor: 5.150

6.  Quercetin Suppresses the Migration and Invasion in Human Colon Cancer Caco-2 Cells Through Regulating Toll-like Receptor 4/Nuclear Factor-kappa B Pathway.

Authors:  Mingyang Han; Yucheng Song; Xuedong Zhang
Journal:  Pharmacogn Mag       Date:  2016-05-11       Impact factor: 1.085

7.  The Mycoplasma hyorhinis p37 Protein Rapidly Induces Genes in Fibroblasts Associated with Inflammation and Cancer.

Authors:  Amber Cathie Gomersall; Huy Anh Phan; Sylvana Iacuone; Song Feng Li; Roger W Parish
Journal:  PLoS One       Date:  2015-10-29       Impact factor: 3.240

8.  Microbial infection, inflammation and epithelial ovarian cancer.

Authors:  Xiaohui Xie; Mengyuan Yang; Yiling Ding; Jianlin Chen
Journal:  Oncol Lett       Date:  2017-06-15       Impact factor: 2.967

9.  Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition.

Authors:  Dongsheng Huang; Hongying Duan; Hao Huang; Xiangmin Tong; Yong Han; Guoqing Ru; Like Qu; Chengchao Shou; Zhongsheng Zhao
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

10.  Mycoplasma-associated multidrug resistance of hepatocarcinoma cells requires the interaction of P37 and Annexin A2.

Authors:  Danyang Liu; Yang Hu; Ying Guo; Zhu Zhu; Bingzheng Lu; Xuelan Wang; Yijun Huang
Journal:  PLoS One       Date:  2017-10-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.